These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19099260)

  • 1. Assaying Wnt5A-mediated invasion in melanoma cells.
    O'Connell MP; French AD; Leotlela PD; Weeraratna AT
    Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
    Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
    Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
    Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
    Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
    Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.
    Webster MR; Xu M; Kinzler KA; Kaur A; Appleton J; O'Connell MP; Marchbank K; Valiga A; Dang VM; Perego M; Zhang G; Slipicevic A; Keeney F; Lehrmann E; Wood W; Becker KG; Kossenkov AV; Frederick DT; Flaherty KT; Xu X; Herlyn M; Murphy ME; Weeraratna AT
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):184-95. PubMed ID: 25407936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
    Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
    J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.
    Hanaki H; Yamamoto H; Sakane H; Matsumoto S; Ohdan H; Sato A; Kikuchi A
    Mol Cancer Ther; 2012 Feb; 11(2):298-307. PubMed ID: 22101459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
    Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
    Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
    O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
    J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
    Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5A activates the calpain-mediated cleavage of filamin A.
    O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
    J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
    Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT5A expression increases during melanoma progression and correlates with outcome.
    Da Forno PD; Pringle JH; Hutchinson P; Osborn J; Huang Q; Potter L; Hancox RA; Fletcher A; Saldanha GS
    Clin Cancer Res; 2008 Sep; 14(18):5825-32. PubMed ID: 18794093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
    Ekström EJ; Sherwood V; Andersson T
    PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion.
    You J; Miele ME; Dong C; Welch DR
    Biochem Biophys Res Commun; 1995 Mar; 208(2):476-84. PubMed ID: 7695596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
    Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
    Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
    Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S
    Amino Acids; 2008 Feb; 34(2):251-6. PubMed ID: 17356804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.